| Application number | Title of the application | Filing Date | Status |
|---|
| 10/154659 | Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition | May 22, 2002 | Abandoned |
Array
(
[id] => 6870602
[patent_doc_number] => 20030083292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Inhibitors of DNA methyltransferase isoforms'
[patent_app_type] => new
[patent_app_number] => 10/144577
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13515
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083292.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144577 | Inhibitors of DNA methyltransferase isoforms | May 12, 2002 | Abandoned |
Array
(
[id] => 6568170
[patent_doc_number] => 20020165196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Oligonucleotide inhibitors of cancer cell proliferation'
[patent_app_type] => new
[patent_app_number] => 10/141263
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8691
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10141263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/141263 | Oligonucleotide inhibitors of cancer cell proliferation | May 6, 2002 | Abandoned |
Array
(
[id] => 6736001
[patent_doc_number] => 20030013636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Control of immune responses by modulating activity of glycosyltransferases'
[patent_app_type] => new
[patent_app_number] => 10/131721
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18153
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10131721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/131721 | Control of immune responses by modulating activity of glycosyltransferases | Apr 22, 2002 | Abandoned |
| 10/049216 | Medicaments that contain xenogenic oligo-or/and polyribonucleotides | Apr 17, 2002 | Abandoned |
Array
(
[id] => 6801574
[patent_doc_number] => 20030096739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Nuclear receptor-mediated introduction of a PNA into cell nuclei'
[patent_app_type] => new
[patent_app_number] => 10/122973
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9351
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122973 | Nuclear receptor-mediated introduction of a PNA into cell nuclei | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6906158
[patent_doc_number] => 20050101553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Antisense modulation of calreticulin expression'
[patent_app_type] => utility
[patent_app_number] => 10/399890
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23260
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399890 | Antisense modulation of calreticulin expression | Oct 29, 2001 | Abandoned |
Array
(
[id] => 7385910
[patent_doc_number] => 20040082529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Methods and compositions for inducing tumor-specific cytotoxicity'
[patent_app_type] => new
[patent_app_number] => 10/012131
[patent_app_country] => US
[patent_app_date] => 2001-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 31750
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012131 | Methods and compositions for inducing tumor-specific cytotoxicity | Oct 21, 2001 | Issued |
| 09/673994 | Cnre binding factors and uses thereof | Sep 6, 2001 | Abandoned |
Array
(
[id] => 6905603
[patent_doc_number] => 20050100998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Human cytidine monophosphate (cmp) kinase cdna'
[patent_app_type] => utility
[patent_app_number] => 10/362332
[patent_app_country] => US
[patent_app_date] => 2001-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7904
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362332 | Human cytidine monophosphate (cmp) kinase cdna | Aug 14, 2001 | Abandoned |
Array
(
[id] => 779390
[patent_doc_number] => 06995258
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-07
[patent_title] => 'Nucleolar targeting of therapeutics against HIV'
[patent_app_type] => utility
[patent_app_number] => 09/864873
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 42
[patent_no_of_words] => 9022
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/995/06995258.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864873
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864873 | Nucleolar targeting of therapeutics against HIV | May 24, 2001 | Issued |
Array
(
[id] => 7111032
[patent_doc_number] => 20050208487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Immobilized nuckeic acids and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/296506
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12106
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296506 | Immobilized nuckeic acids and uses thereof | May 24, 2001 | Abandoned |
Array
(
[id] => 1059616
[patent_doc_number] => 06852706
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Methods and compositions for healing heart wounds'
[patent_app_type] => utility
[patent_app_number] => 09/813930
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5213
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852706.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813930
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813930 | Methods and compositions for healing heart wounds | Mar 21, 2001 | Issued |
| 09/588314 | METHOD OF PRODUCING HUMAN COAGULATION FACTOR VIII FROM WHOLE PLANTS OR PLANT CELL CULTURES | Jun 5, 2000 | Abandoned |
| 09/548449 | Tissue-specific and pathogen-specific toxic agents and ribozymes | Apr 12, 2000 | Abandoned |
Array
(
[id] => 554547
[patent_doc_number] => 07160868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors'
[patent_app_type] => utility
[patent_app_number] => 09/301380
[patent_app_country] => US
[patent_app_date] => 1999-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 56
[patent_no_of_words] => 36594
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160868.pdf
[firstpage_image] =>[orig_patent_app_number] => 09301380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301380 | Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors | Apr 26, 1999 | Issued |
Array
(
[id] => 554547
[patent_doc_number] => 07160868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors'
[patent_app_type] => utility
[patent_app_number] => 09/301380
[patent_app_country] => US
[patent_app_date] => 1999-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 56
[patent_no_of_words] => 36594
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160868.pdf
[firstpage_image] =>[orig_patent_app_number] => 09301380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301380 | Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors | Apr 26, 1999 | Issued |